Healthstream (HSTM) EBIT (2010 - 2026)

Healthstream (HSTM) has reported EBIT for 17 consecutive years, with $8.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBIT rose 41.37% year-over-year to $8.3 million in Q2 2026; TTM through Jun 2026 was $25.8 million, a 20.29% increase from a year earlier, with the FY2025 full-year figure at $20.2 million, down 4.94% from the prior year.
• EBIT was $8.3 million for Q2 2026 at Healthstream, up from $7.5 million in the prior quarter.
• Over five years, EBIT peaked at $8.3 million in Q2 2026 and troughed at $2.4 million in Q3 2022.
• A 5-year average of $4.8 million and a median of $4.4 million in 2024 frame the typical range for EBIT.
• Across the five-year window, EBIT soared 768.91% in 2022 and sank 48.73% in 2025, its largest moves.
• Over 5 years, EBIT stood at $3.1 million in 2022, then soared by 38.25% to $4.3 million in 2023, then climbed by 10.23% to $4.7 million in 2024, then plunged by 48.73% to $2.4 million in 2025, then surged by 246.13% to $8.3 million in 2026.
• The last three EBIT figures came in at $8.3 million (Q2 2026), $7.5 million (Q1 2026), and $2.4 million (Q4 2025), per Business Quant data.